News Line

Scientific Boston leads Sale hearing Business and drug pump Development Program through

Posted on January 5th, 2008 by admin

NATICK, measure, January. 04, 2008 /PRNewswire FirstCall over COMTEX/ — Boston Scientific corporation ( NYSE: BSX) today announces that it accomplished the sale of the participations of the majority at its hearing business and drug pump development program for former management and to the shareholders of the advanced bionics. Boston scientific acquired advanced bionics 2004. The sale agrees with the closing of the changed merger agreement with the advanced bionics, die on August 9, 2007 is announced. As a new schedule united, locally specified earnout payments, scientific Boston more former advanced bionics shareholders $650 million part paid. One final payment of $500 million is paid to Boston scientific $150 million in March 2009 paid Die more former advanced bionics management and shareholders to have for die participations of the majority at the hearing business and drug pump development program. more Under the changed merger agreement, Boston, which is scientific, achieves the exclusive management control Pain management business and including emerging indicating program. Kw_Pain the management business includes suggestion for back Mark, as well as emerging technologies like a multiplicity of applications bion(R) microstimulator. Kw_Pain the management business and emerging indicating program let run as Boston scientific neuro modulation more under die guidance from Michael Onuscheck, at present head Pain management business. Kw_business drives fort in the Valencia, California to be had. As the negotiations, are die parties part in agreement ge$$$WESEN to dismiss during law case between Boston the scientific and more former advanced bionics shareholders at present. Scientific Boston is a world-wide developer, manufacturer and a marketer of the medical devices whose products in one broad distance interventional the medical special fields is used. To more information please visit: www.bostonscientific.com. concerning Die caution rushing legend statements are This press release forward look contain the forward looking of of statements within the meaning of Section 21E collateral Exchange Act from 1934. the forward looking may of the statements by words, how “you,” ” expect, anticipate” “project are marked,” “believe you,” “plan,” “estimation,” “intend you” and similar words. These forwardlooking statements are based on our the faith, acceptance and estimations, which die information using is, die for us to time are present and should not warranties future cases or the achievement be. These, die statements include, under other things, concerning die statements are our repulsion of capital abilities of the non-strategic values, our die restructuring initiatives, our functional strategy, our financial achievement and our growth strategy forward looking. If our underlying accepting turn out, to be to wrong or if certain dangers or uncertainties carry out, actual results could vary by expectations and by the projections materially, die through our forwardlooking statements were expressed or were suggested. These factors in some cases affected and in future (more together with other factors) could our ability affect, in order to introduce our business strategy and may cause actual results to more differ of those materially, which was considered by die statements, die into this were expressed, die press to release. As to be result readers not place to the excessive confidence on any our the forwardlooking statements warned. Factors die may cause such differences include, under other things: future economically, competing, remuneration and regulating conditions; new product introduction; demographic tendencies; intellectual property; Law case; financial market conditions; and, future business decisions met through us and our competitors. All these factors are difficult, or impossible, to forecast exactly and many of them are beyond our control. For more further list and a description of this and more other from from important dangers and uncertainties, which may our future enterprises, see Part I, individual part 1A danger factors in our affects you, arranged most new annual Report on form 10-K with the shares and the Exchange commission, die we may updates into Part II, individual part 1A - danger factors in the quarterly reports over form 10-Q we arranged or thereafter will arrange. We disclaim each possible intention or obligation of updating or of improving any forwardlooking statements publicly, in order to reflect each possible change in our expectations or in the cases, in the conditions or in the circumstances, on which die may those expectations are based, or this may affect die probability, which actual results more differ of those sake, which will contain in the forwardlooking statements. This caution rushing legend is applicable to all forwardlooking statements, die in this the document to be contained.

CONTACT: Paul Donovan 508-650-8541 ( office) 508-667-5165 (mobile) Media relation Boston Scientific corporation

Dan Brennan 508-650-8538 ( office) (mobile) 617-459-2703 relations between the Investorenboston Scientific corporation QUELLBOSTON Scientific corporation http://www.bostonscientific.com copyright Â © photo receptor 2008 Newswire. All rights reserve

**********************************************************************

Starting from Monday 12-31 2007 23:59, the newest Comtex SmarTrendÂ® alarm, an automated pattern recognition system, indicated a DOWNWARD TENDENCY on 11-01 2007 for BSX @ to $13,43.

To more information about SmarTrend, you approach data servicers their market or go you too www.mysmartrend.com